Download free COVID Alert app.
Official Site of The State of New Jersey
Information for Healthcare Providers and Local Health Departments
- Severe Manifestations of mpox among People who are Immunocompromised Due to HIV or Other Conditions (CDC HAN) NEW 9/30/2022
- JYNNEOS intradermal vaccine preparation and administration summary
- How to administer a JYNNEOS vaccine intradermally video (CDC)
- JYNNEOS Storage and Handling Summary
- How to Collect a mpox Specimen for Diagnostic Testing (NETEC)
- Standing Order for Medical Management of Vaccine Reactions in Adults in a Community Setting UPDATED 9/6/2022
- Standing Order for mpox Virus Vaccine - JYNNEOS UPDATED 9/6/2022
- Contact Monitoring Guidance
- Guidance for Expanded mpox Post-Exposure Prophylaxis (PEP++) (LINCS)
- Mpox Vaccine Considerations
- Laboratory Testing Approval Guidance (LINCS)
- Information on TPOXX (Tecovirimat) for mpox Cases (LINCS) UPDATED 11/15/2022
- Updated Guidance for NJ Healthcare Providers (LINCS)
- Mpox Virus Infection in the U.S. and Other Non-Endemic Countries (LINCS)
- Information for Clinicians (CDC)
- Streamlined Process to Provide Tecovirimat (TPOXX) for Treatment of mpox (CDC)
Laboratory Testing Information
Information for Veterinarians
- Information for Veterinarians (CDC)
- Pets in the Home (CDC)
Disease Reporting
- Communicable Disease Manual Chapter UPDATED 9/27/2022
- Mpox Investigation Form